miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1

miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1

MicroRNAs (miRNAs) family, which is involved in cancer development, proliferation, apoptosis, and drug resistance, is a group of noncoding RNAs that modulate the expression of oncogenes and antioncogenes. Doxorubicin is an active cytotoxic agent for breast cancer treatment, but the acquisition of do...

Full description

Bibliographic Details
Main Authors:	Jingpei Long, Zhiwei Ji, Kai Jiang, Zhaoyang Wang, Guanmin Meng
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2015/373574

Similar Items

MiR193a Modulation and Podocyte Phenotype
by: Alok Jha, et al.
Published: (2020-04-01)

Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1
by: Shi-shuo Wang, et al.
Published: (2020-02-01)

Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma
by: Esperanza M. Algarín, et al.
Published: (2021-03-01)

The Foods Containing miR-193b May Inhibit the Growth of Breast Cancer Cells
by: Dilek Asci Celik, et al.
Published: (2017-11-01)

Inhibition of breast cancer metastasis by co-transfection of miR-31/193b-mimics
by: Zahra Sadat Hashemi, et al.
Published: (2018-04-01)

Clinical significance of miR-140-5p and miR-193b expression in patients with breast cancer and relationship to IGFBP5
by: Gökçe Güllü, et al.
Published: (2015-03-01)

MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth.
by: Colin Moore, et al.
Published: (2017-01-01)

Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN
by: Lingqi Liu, et al.
Published: (2017-06-01)

Bimodal Epigenetic Control of miR193a in Ovarian Cancer
by: Hsueh-Tse Cheng, et al.
Published: (2013)

The transcriptional regulation of miR-193b in lung adenocarcinoma cells
by: Ching Lin, et al.
Published: (2016)

Is the Dietary miR-193b a Novel Cell Cycle Arresting Source for Breast Carcinoma?
by: Nilgun Gurbuz, et al.
Published: (2017-11-01)

MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1.
by: Jie Gao, et al.
Published: (2013-01-01)

Circular RNA circHIPK3 promotes cell proliferation and invasion of prostate cancer by sponging miR-193a-3p and regulating MCL1 expression
by: Chen D, et al.
Published: (2019-02-01)

miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer
by: Shihua Wu, et al.
Published: (2015-01-01)

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
by: Richer Jennifer K, et al.
Published: (2010-12-01)

Correction: MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
by: Jie Gao, et al.
Published: (2013-01-01)

Correction: MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1.
by: Jie Gao, et al.
Published: (2013-01-01)

Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer
by: Adriane F. Evangelista, et al.
Published: (2021-01-01)

Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer
by: Bin Song, et al.
Published: (2018-11-01)

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
by: Oshrat Hershkovitz Rokah, et al.
Published: (2012-01-01)

Down-regulation of miR-193b-3p and miR-376a-3p in Chronic Lymphocytic Leukemia
by: Faezeh Namazi, et al.
Published: (2018-12-01)

MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1
by: Julie-Ann Hulin, et al.
Published: (2017-10-01)

Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells
by: Y. Fang, et al.
Published: (2014-01-01)

Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy
by: Sama Izadpanah, et al.
Published: (2019-03-01)

Regulation and metastasis-related targets of miR-193b in lung cancer cells
by: Che-Wei Liu, et al.
Published: (2014)

miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer
by: Yan Li, et al.
Published: (2019-10-01)

miR-26a Reverses Multidrug Resistance in Osteosarcoma by Targeting MCL1
by: Ming Li, et al.
Published: (2021-03-01)

Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
by: Zhan Yang, et al.
Published: (2017-12-01)

Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer.
by: Xianglan Jin, et al.
Published: (2015-01-01)

Restoring of miR-193a-5p Sensitizes Breast Cancer Cells to Paclitaxel through P53 Pathway
by: Monireh Khordadmehr, et al.
Published: (2020-08-01)

MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression
by: Yun Teng, et al.
Published: (2017-02-01)

Enhancement of myogenic differentiation and inhibition of rhabdomyosarcoma progression by miR-28-3p and miR-193a-5p regulated by SNAIL
by: Klaudia Skrzypek, et al.
Published: (2021-06-01)

MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
by: FeiYan Xie, et al.
Published: (2017-01-01)

Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients
by: Li M, et al.
Published: (2018-10-01)

The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer
by: Soheila Delgir, et al.
Published: (2021-07-01)

Honokiol Suppressed Pancreatic Cancer Progression via miR-101/Mcl-1 Axis
by: Wang Y, et al.
Published: (2020-07-01)

Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.
by: Prasun J Mishra, et al.
Published: (2016-01-01)

Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy
by: Deepak Bhere, et al.
Published: (2020-02-01)

miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer’s Patients
by: Diana J. Cha, et al.
Published: (2019-11-01)

miR‐138 and miR‐193 target long non‐coding RNA UCA1 to inhibit cell proliferation, migration, and invasion of lung cancer
by: Guangsu Xun, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_v4sahlolp7lem09qb663hbv49n